Human NSCLC cell lines A549 (KCLB No. 10185), NCI-H1299 (KCLB No. 25803), NCI-H1650 (KCLB No. 91650), and HCC827 (KCLB No. 70827) were obtained from the Korean Cell Line Bank (Seoul, Republic of Korea). The identity of each cell line was confirmed by STR profiling: A549 (D3S1358: 16; vWA: 14; FGA: 23; Amelogenin: X,Y; TH01: 8,9.3; TPOX: 8,11; CSF1PO: 10,12; D5S818: 11; D13S317: 11; D7S820: 8,11), NCI-H1299 (D3S1358: 17; vWA: 16,18; FGA: 20; Amelogenin: X; TH01: 6,9.3; TPOX: 8; CSF1PO: 12; D5S818: 11; D13S317: 12; D7S820: 10), NCI-H1650 (D3S1358: 18; vWA: 18; FGA: 20,23.2; Amelogenin: X; TH01: 9.3; TPOX: 11; CSF1PO: 11; D5S818: 11; D13S317: 11; D7S820: 8,9), and HCC827 (D3S1358: OL; vWA: 18; FGA: 22,24; Amelogenin: X; TH01: 6; TPOX: 8; CSF1PO: 11; D5S818: 12; D13S317: 9; D7S820: 11,12). CSCs were propagated from NSCLC cell lines as tumorspheres under CSC-selective culture conditions, and their stem properties were confirmed as previously described [23 (link),24 (link),25 (link)]. NSCLC tumorsphere cells were cultured in serum-free DMEM/F12 containing 20 ng/mL EGF, 20 ng/mL bFGF, 1 × B-27, 5 μg/mL heparin, 2 mM L-glutamine, and 1% penicillin/streptomycin. Tumorspheres were subcultured through dissociation with Accutase. The cells were maintained at 37 °C in a humidified CO2 incubator with 5% CO2 (Thermo Scientific, Vantaa, Finland).
Free full text: Click here